Альманах клинической медицины. 2014; : 106-107
ФОТОФЕРЕЗ В КОМПЛЕКСНОМ ЛЕЧЕНИИ УРОГЕНИТАЛЬНОГО РЕАКТИВНОГО АРТРИТА (БОЛЕЗНИ РЕЙТЕРА)
https://doi.org/10.18786/2072-0505-2014-34-106-107Аннотация
Список литературы
1. Ковалев ЮН, Ильин ИИ. Болезнь Рейтера. Челябинск: Вариант-книга; 1993. 224 c. (Kovalev YuN, Il’in II. Reiter’s disease. Chelyabinsk: Variant-kniga; 1993. 224 p. Russian).
2. Carter JD, Gérard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, Oszust C, Vasey FB, Hudson AP. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum. 2009;60(5):1311–6.
3. Хансфилд Х. Заболевания, передающиеся половым путем. Цветной атлас-справочник. [Пер. с англ.]. М.: БИНОМ; 2004. 296 c. (Handsfield H. Sexually transmitted diseases. Color reference atlas. Moscow: BINOM; 2004. 296 p. Russian).
4. Arora S, Arora G. Reiter’s disease in a six-year-old girl. Indian J Dermatol Venereol Leprol. 2005;71(4):285–6.
5. Laasila K, Laasonen L, Leirisalo-Repo M. Antibiotic treatment and long term prognosis of reactive arthritis. Ann Rheum Dis. 2003;62(7):655–8.
6. Magro СM, Crowson AN, Peeling R. Vasculitis as the basis of cutaneous lesions in Reiter’s disease. Hum Pathol. 1995;26(6):633–8.
7. Mazzoli S, Meacci F, Cosco E, Poggiali C. Clinical consequences of immune responses to Chlamydia in men. Infect Dis Obstet Gynecol. 1996;4(3):136–42.
8. Молочков ВА, Альбанова ВИ, Петрова МС, Белецкая ЛВ. Результаты сравнительных гистологических и иммуноморфологических изменений кожи при болезни Рейтера и псориазе. Российский журнал кожных и венерических болезней. 2001;(3):13–7. (Molochkov VA, Al’banova VI, Petrova MS, Beletskaya LV. [Comparison of histological and immunomorphological skin changes in Reiter’s disease and psoriasis]. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney. 2001;(3):13–7. Russian).
9. Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR Jr, Budiman-Mak E, Balestra DJ, Blackburn WD, Cannon GW, Inman RD, Alepa FP, Mejias E, Cohen MR, Makkena R, Mahowald ML, Higashida J, Silverman SL, Par-hami N, Buxbaum J, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Ward JR, Hender-son WG. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter’s syndrome). A department of veterans affairs cooperative study. Arthritis Rheum. 1996;39(12):2021–7.
10. Louthrenoo W. Successful treatment of severe Reiter’s syndrome associated with human immunodeficiency virus infection with etretinate. Report of 2 cases. J Rheumatol. 1993;20(7):1243–6.
11. Williams HC, Du Vivier AW. Etretinate and AIDS-related Reiter’s disease. Br J Dermatol. 1991;124(4):389–92.
12. Yli-Kerttula T, Möttönen T, Toivanen A. Different course of reactive arthritis in two HLA-B27 positive brothers with fatal outcome in one. J Rheumatol. 1997;24(10):2047–50.
13. Meador R, Hsia E, Kitumnuaypong T, Schumacher HR. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis. Clin Exp Rheumatol. 2002;20(6 Suppl 28):S130–4.
14. Kaipiainen-Seppänen O, Niinisalo H, Korpilähde T, Virolainen J. Treatment of reactive arthritis with infliximab. Scand J Rheumatol. 2003;32(2):122–4.
15. Felipe OJ, Beltrán A, Romero MC, Valle RR. Сlinical response to infliximad in a patient diagnosed with reactive arthritis at the hospital militar central in Bogota. J Clin Rheumatol. 2006;12 Suppl 4:S68.
16. Rihl M, Klos A, Köhler L, Kuipers JG. Infection and musculoskeletal conditions: Reactive arthritis. Best Pract Res Clin Rheumatol. 2006;20(6): 1119–37.
17. Flores D, Marquez J, Garza M, Espinoza LR. Reactive arthritis: newer developments. Rheum Dis Clin North Am. 2003;29(1):37–59.
18. Молочков ВА, Ильин ИИ. Хронический уретрогенный простатит. М.: Медицина; 2004. 288 c. (Molochkov VA, Il’in II. Chronic urethrogenic prostatitis. Moscow: Meditsina; 2004. 288 p. Russian).
Almanac of Clinical Medicine. 2014; : 106-107
PHOTOPHERESIS IN THE COMPREHENSIVE TREATMENT OF UROGENITAL REACTIVE ARTHRITIS (REITER’S DISEASE)
https://doi.org/10.18786/2072-0505-2014-34-106-107Abstract
References
1. Kovalev YuN, Il'in II. Bolezn' Reitera. Chelyabinsk: Variant-kniga; 1993. 224 c. (Kovalev YuN, Il’in II. Reiter’s disease. Chelyabinsk: Variant-kniga; 1993. 224 p. Russian).
2. Carter JD, Gérard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, Oszust C, Vasey FB, Hudson AP. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis Rheum. 2009;60(5):1311–6.
3. Khansfild Kh. Zabolevaniya, peredayushchiesya polovym putem. Tsvetnoi atlas-spravochnik. [Per. s angl.]. M.: BINOM; 2004. 296 c. (Handsfield H. Sexually transmitted diseases. Color reference atlas. Moscow: BINOM; 2004. 296 p. Russian).
4. Arora S, Arora G. Reiter’s disease in a six-year-old girl. Indian J Dermatol Venereol Leprol. 2005;71(4):285–6.
5. Laasila K, Laasonen L, Leirisalo-Repo M. Antibiotic treatment and long term prognosis of reactive arthritis. Ann Rheum Dis. 2003;62(7):655–8.
6. Magro SM, Crowson AN, Peeling R. Vasculitis as the basis of cutaneous lesions in Reiter’s disease. Hum Pathol. 1995;26(6):633–8.
7. Mazzoli S, Meacci F, Cosco E, Poggiali C. Clinical consequences of immune responses to Chlamydia in men. Infect Dis Obstet Gynecol. 1996;4(3):136–42.
8. Molochkov VA, Al'banova VI, Petrova MS, Beletskaya LV. Rezul'taty sravnitel'nykh gistologicheskikh i immunomorfologicheskikh izmenenii kozhi pri bolezni Reitera i psoriaze. Rossiiskii zhurnal kozhnykh i venericheskikh boleznei. 2001;(3):13–7. (Molochkov VA, Al’banova VI, Petrova MS, Beletskaya LV. [Comparison of histological and immunomorphological skin changes in Reiter’s disease and psoriasis]. Rossiyskiy zhurnal kozhnykh i venericheskikh bolezney. 2001;(3):13–7. Russian).
9. Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR Jr, Budiman-Mak E, Balestra DJ, Blackburn WD, Cannon GW, Inman RD, Alepa FP, Mejias E, Cohen MR, Makkena R, Mahowald ML, Higashida J, Silverman SL, Par-hami N, Buxbaum J, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Ward JR, Hender-son WG. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter’s syndrome). A department of veterans affairs cooperative study. Arthritis Rheum. 1996;39(12):2021–7.
10. Louthrenoo W. Successful treatment of severe Reiter’s syndrome associated with human immunodeficiency virus infection with etretinate. Report of 2 cases. J Rheumatol. 1993;20(7):1243–6.
11. Williams HC, Du Vivier AW. Etretinate and AIDS-related Reiter’s disease. Br J Dermatol. 1991;124(4):389–92.
12. Yli-Kerttula T, Möttönen T, Toivanen A. Different course of reactive arthritis in two HLA-B27 positive brothers with fatal outcome in one. J Rheumatol. 1997;24(10):2047–50.
13. Meador R, Hsia E, Kitumnuaypong T, Schumacher HR. TNF involvement and anti-TNF therapy of reactive and unclassified arthritis. Clin Exp Rheumatol. 2002;20(6 Suppl 28):S130–4.
14. Kaipiainen-Seppänen O, Niinisalo H, Korpilähde T, Virolainen J. Treatment of reactive arthritis with infliximab. Scand J Rheumatol. 2003;32(2):122–4.
15. Felipe OJ, Beltrán A, Romero MC, Valle RR. Slinical response to infliximad in a patient diagnosed with reactive arthritis at the hospital militar central in Bogota. J Clin Rheumatol. 2006;12 Suppl 4:S68.
16. Rihl M, Klos A, Köhler L, Kuipers JG. Infection and musculoskeletal conditions: Reactive arthritis. Best Pract Res Clin Rheumatol. 2006;20(6): 1119–37.
17. Flores D, Marquez J, Garza M, Espinoza LR. Reactive arthritis: newer developments. Rheum Dis Clin North Am. 2003;29(1):37–59.
18. Molochkov VA, Il'in II. Khronicheskii uretrogennyi prostatit. M.: Meditsina; 2004. 288 c. (Molochkov VA, Il’in II. Chronic urethrogenic prostatitis. Moscow: Meditsina; 2004. 288 p. Russian).
